[HTML][HTML] Development of a novel intra-operative score to record diseases' anatomic fingerprints (ANAFI score) for the prediction of complete cytoreduction in advanced …

A Laios, E Kalampokis, R Johnson, S Munot… - Cancers, 2023 - mdpi.com
Simple Summary The current scoring systems fail to reflect the patient's real anatomy, as
seen by the surgeon upon cytoreduction for advanced-stage epithelial ovarian cancer …

Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced …

A Laios, E Kalampokis, R Johnson, S Munot… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: The current scoring systems fail to reflect the patient's real
anatomy, as seen by the surgeon upon cytoreduction for advanced-stage epithelial ovarian …

Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced …

A Laios, E Kalampokis, R Johnson, S Munot… - Cancers, 2023 - europepmc.org
Background: The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for
Ovarian Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …

[PDF][PDF] Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in …

A Laios, E Kalampokis, R Johnson, S Munot… - 2023 - researchgate.net
Background: The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for
Ovarian Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …

[HTML][HTML] Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in …

A Laios, E Kalampokis, R Johnson, S Munot… - Cancers, 2023 - ncbi.nlm.nih.gov
Background: The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for
Ovarian Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …

[PDF][PDF] Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in …

A Laios, E Kalampokis, R Johnson, S Munot… - 2023 - academia.edu
Background: The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for
Ovarian Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …

Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced …

A Laios, E Kalampokis, R Johnson, S Munot… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for Ovarian
Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …

Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced …

A Laios, E Kalampokis, R Johnson, S Munot… - …, 2023 - search.proquest.com
Background: The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for
Ovarian Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …

[PDF][PDF] Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in …

A Laios, E Kalampokis, R Johnson, S Munot… - 2023 - academia.edu
Background: The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for
Ovarian Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …

Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced …

A Laios, E Kalampokis, R Johnson, S Munot… - Cancers, 2023 - europepmc.org
Background The Peritoneal Carcinomatosis Index (PCI) and the Intra-operative Mapping for
Ovarian Cancer (IMO), to a lesser extent, have been universally validated in advanced-stage …